Hardik Parikh
Stock Analyst at J.P. Morgan
(0.49)
# 4,150
Out of 4,534 analysts
25
Total ratings
32%
Success rate
-9.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintained: Buy | n/a | $46.98 | - | 6 | Jun 9, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | $30 | $17.91 | +67.50% | 1 | May 12, 2026 | |
| PCRX Pacira BioSciences | Maintained: Sell | $23 | $25.35 | -9.27% | 11 | Mar 20, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $75 | $36.38 | +106.16% | 7 | Feb 11, 2026 |
Structure Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $46.98
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $17.91
Upside: +67.50%
Pacira BioSciences
Mar 20, 2026
Maintained: Sell
Price Target: $23
Current: $25.35
Upside: -9.27%
Viking Therapeutics
Feb 11, 2026
Maintained: Buy
Price Target: $75
Current: $36.38
Upside: +106.16%